IP Library › Patent Application 17726271
Patent Application
App. No. 17/726,271

Cryopreservation compositions and methods involving nanowarming

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/726,271
Abstract

A cryopreservation composition generally includes a cryoprotective agent and a laser absorber that includes a metal. Rewarming a cryopreserved specimen that includes the cryopreservation composition includes subjecting the cryopreserved specimen to a laser pulse effective to heat the laser absorber sufficiently to thaw the cryopreserved biospecimen.

Claims (29)

1 . A method of warming a cryopreserved biospecimen, the method comprising:

obtaining a cryopreserved specimen comprising a cryoprotective composition, the cryoprotective composition comprising:

a cryoprotective agent; and

a laser absorber comprising a plasmonic material, wherein the plasmonic material absorbs a narrow band of laser energy; and

subjecting the cryopreserved specimen to a laser pulse effective to heat the laser absorber sufficiently to rewarm the cryopreserved biospecimen.

2 . The method of claim 1 , wherein the laser absorber comprises a metal.

3 . The method of claim 2 , wherein the metal is selected from gold, silver, titanium, copper or combinations thereof.

4 . The method of claim 1 , wherein the laser absorber comprises a gold nanorod.

5 . The method of claim 1 , wherein the cryopreserved specimen is irradiated with visible or near infrared radiation (NIR) for rewarming the cryopreserved specimen.

6 . The method of claim 1 , wherein the wavelength of the laser pulse to heat the laser absorbers is between about 400 nm and about 2500 nm.

7 . The method of claim 1 , wherein the laser absorbers have an absorption efficiency (Qabs) of greater than 2.

8 . The method of claim 1 , wherein the laser absorbers have an absorption efficiency (Qabs) of greater than 10.

9 . The method of claim 1 , wherein the laser absorbers are injected into the cryopreserved specimen prior to cryopreservation.

10 . The method of claim 1 , wherein the laser absorber is not toxic when injected into the cryopreserved specimen.

11 . The method of claim 1 , wherein the cryopreserved specimen comprises cells, oocytes, embryos, tissue, tissue portions, neural cells, ganglia, stem cell derived spheroids, cornea, skin, thin tissues and combinations thereof.

12 . The method of claim 1 , wherein the cryopreserved specimen is perfused with the cryoprotective composition.

13 . The method of claim 1 , wherein the cryopreserved specimen is suspended in the cryoprotective composition.

14 . The method of claim 1 wherein the laser absorbers are distributed in all compartments of the cell.

15 . The method of claim 14 , wherein the cell is an oocyte and the laser absorber is distributed in the chorion and the yolk.

16 . The method of claim 1 , wherein the cryoprotective agent comprises propylene glycol, trehalose, polyethylene glycol, methanol or combinations thereof.

17 . The method of claim 1 , wherein the laser pulse produces a warming rate of at least 500,000° C./min.

18 . A method of cryopreserving a biospecimen, the method comprising:

cooling the biospecimen in a cryoprotective composition to generate a cryopreserved biospecimen, the cryoprotective composition comprising:

a cryoprotective agent; and

a laser absorber comprising a plasmonic material, wherein the plasmonic material absorbs a narrow band of laser energy; and

obtaining the cryopreserved specimen for rewarming; and

subjecting the cryopreserved specimen to a laser pulse effective to heat the laser absorber sufficiently to rewarm the cryopreserved biospecimen.

19 . The method of claim 18 , wherein the biospecimen is injected with the laser absorber prior to cooling.

20 . The method of claim 18 , wherein the biospecimen is perfused with or suspended in the cryoprotective composition.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2022
From: HAGEDORN, MARY MARGARET
To: SMITHSONIAN INSTITUTION
Reel/Frame 059728/0774 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2022
From: KHOSLA, KANAV; BISCHOF, JOHN
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 059728/0836 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2022
From: QIN, ZHENPENG
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 059754/0995 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2022
From: DUTCHER, CARI SUZANNE
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 059755/0035 →